• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉毛细血管中的钠-葡萄糖协同转运蛋白可增加葡萄糖通透性。

Na(+)-D-glucose cotransporter in muscle capillaries increases glucose permeability.

作者信息

Elfeber Katrin, Stümpel Frank, Gorboulev Valentin, Mattig Sabine, Deussen Andreas, Kaissling Brigitte, Koepsell Hermann

机构信息

Institut für Anatomie und Zellbiologie der Bayerischen Julius-Maximilians-Universität, Koellikerstrasse 6, 97070 Würzburg, Germany.

出版信息

Biochem Biophys Res Commun. 2004 Feb 6;314(2):301-5. doi: 10.1016/j.bbrc.2003.12.090.

DOI:10.1016/j.bbrc.2003.12.090
PMID:14733905
Abstract

By immunohistochemistry, we demonstrated the localization of the Na(+)-D-glucose cotransporter SGLT1 in capillaries of rat heart and skeletal muscle, but not in capillaries of small intestine and submandibular gland. mRNA of SGLT1 was identified in skeletal muscle and primary cultured coronary endothelial cells. The functional relevance of SGLT1 for glucose transport across capillary walls in muscle was tested by measuring the extraction of D-glucose from the perfusate during non-recirculating perfusion of isolated rat hindlimbs. In this model, D-glucose extraction from the perfusate is increased by insulin which accelerates D-glucose uptake into myocytes by increasing the concentration of glucose transporter GLUT4 in the plasma membrane. The insulin-induced increase of D-glucose extraction from the perfusate was abolished after blocking SGLT1 with the specific inhibitor phlorizin. The data show that SGLT1 in capillaries of skeletal muscle is required for the action of insulin on D-glucose supply of myocytes.

摘要

通过免疫组织化学方法,我们证实了Na(+)-D-葡萄糖共转运蛋白SGLT1在大鼠心脏和骨骼肌的毛细血管中定位,但在小肠和下颌下腺的毛细血管中未定位。在骨骼肌和原代培养的冠状动脉内皮细胞中鉴定出SGLT1的mRNA。通过在离体大鼠后肢非循环灌注期间测量灌注液中D-葡萄糖的摄取量,测试了SGLT1在肌肉中跨毛细血管壁转运葡萄糖的功能相关性。在该模型中,灌注液中D-葡萄糖的摄取量因胰岛素而增加,胰岛素通过增加质膜中葡萄糖转运蛋白GLUT4的浓度来加速D-葡萄糖摄取到心肌细胞中。在用特异性抑制剂根皮苷阻断SGLT1后,胰岛素诱导的灌注液中D-葡萄糖摄取量增加被消除。数据表明,骨骼肌毛细血管中的SGLT1是胰岛素作用于心肌细胞D-葡萄糖供应所必需的。

相似文献

1
Na(+)-D-glucose cotransporter in muscle capillaries increases glucose permeability.肌肉毛细血管中的钠-葡萄糖协同转运蛋白可增加葡萄糖通透性。
Biochem Biophys Res Commun. 2004 Feb 6;314(2):301-5. doi: 10.1016/j.bbrc.2003.12.090.
2
Localization of the Na+-D-glucose cotransporter SGLT1 in the blood-brain barrier.钠 - D - 葡萄糖共转运蛋白SGLT1在血脑屏障中的定位。
Histochem Cell Biol. 2004 Mar;121(3):201-7. doi: 10.1007/s00418-004-0633-9. Epub 2004 Feb 19.
3
Expression of glucose transporters in human peritoneal mesothelial cells.葡萄糖转运蛋白在人腹膜间皮细胞中的表达
Kidney Int. 1998 May;53(5):1278-87. doi: 10.1046/j.1523-1755.1998.00899.x.
4
Endothelial Na+-D-glucose cotransporter: no role in insulin-mediated glucose uptake.内皮钠-葡萄糖协同转运蛋白:在胰岛素介导的葡萄糖摄取中不起作用。
Horm Metab Res. 2005 Nov;37(11):657-61. doi: 10.1055/s-2005-870574.
5
Mice without the regulator gene Rsc1A1 exhibit increased Na+-D-glucose cotransport in small intestine and develop obesity.缺乏调节基因Rsc1A1的小鼠在小肠中表现出钠-葡萄糖协同转运增加,并出现肥胖。
Mol Cell Biol. 2005 Jan;25(1):78-87. doi: 10.1128/MCB.25.1.78-87.2005.
6
Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle.大鼠骨骼肌和心肌脂质输注期间FAT/CD36、UCP2、UCP3和GLUT4基因表达的变化
Int J Obes Relat Metab Disord. 2002 Jun;26(6):838-47. doi: 10.1038/sj.ijo.0802005.
7
Sulfonylureas stimulate glucose uptake through GLUT4 transporter translocation in rat skeletal muscle.磺脲类药物通过GLUT4转运体转位刺激大鼠骨骼肌对葡萄糖的摄取。
Biochem Biophys Res Commun. 1996 Nov 12;228(2):499-504. doi: 10.1006/bbrc.1996.1689.
8
Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner.用5-氨基咪唑-4-甲酰胺-1-β-D-呋喃核糖苷进行长期治疗可增加胰岛素刺激的大鼠骨骼肌葡萄糖摄取及GLUT4转位,且具有纤维类型特异性。
Diabetes. 2001 Jan;50(1):12-7. doi: 10.2337/diabetes.50.1.12.
9
Evidence for the regulation of small intestinal Na+/glucose cotransporter by insulin.胰岛素对小肠钠/葡萄糖协同转运蛋白调节作用的证据。
Biochem Mol Biol Int. 1995 Sep;37(1):33-8.
10
Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil.多次给予5-氟尿嘧啶后大鼠小肠葡萄糖吸收增强。
Chem Biol Interact. 2005 Aug 15;155(3):129-39. doi: 10.1016/j.cbi.2005.04.001.

引用本文的文献

1
Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery Systems-A Literature Review.SGLT-2 抑制剂在使用自动胰岛素输送系统的 1 型糖尿病患者中的风险和益处——文献综述。
Int J Mol Sci. 2024 Feb 6;25(4):1972. doi: 10.3390/ijms25041972.
2
Ginsenoside Rd protects cerebral endothelial cells from oxygen-glucose deprivation/reoxygenation induced pyroptosis via inhibiting SLC5A1 mediated sodium influx.人参皂苷Rd通过抑制SLC5A1介导的钠内流,保护脑内皮细胞免受氧糖剥夺/复氧诱导的细胞焦亡。
J Ginseng Res. 2022 Sep;46(5):700-709. doi: 10.1016/j.jgr.2022.05.006. Epub 2022 May 21.
3
Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson's disease in rats.
恩格列净通过抗氧化、抗炎以及调节大鼠鱼藤酮诱导的帕金森病中α-突触核蛋白和帕金蛋白水平来减轻神经退行性变。
Saudi Pharm J. 2022 Jun;30(6):863-873. doi: 10.1016/j.jsps.2022.03.005. Epub 2022 Mar 16.
4
Effects of SGLT2 Inhibitors beyond Glycemic Control-Focus on Myocardial SGLT1.SGLT2 抑制剂的血糖控制以外的作用-关注心肌 SGLT1。
Int J Mol Sci. 2021 Sep 12;22(18):9852. doi: 10.3390/ijms22189852.
5
Sodium-glucose cotransporters: Functional properties and pharmaceutical potential.钠-葡萄糖共转运蛋白:功能特性和药物潜力。
J Diabetes Investig. 2020 Jul;11(4):770-782. doi: 10.1111/jdi.13255. Epub 2020 Apr 16.
6
Effects of the dual sodium-glucose linked transporter inhibitor, licogliflozin vs placebo or empagliflozin in patients with type 2 diabetes and heart failure.双重钠-葡萄糖协同转运蛋白抑制剂利格列净与安慰剂或恩格列净对2型糖尿病合并心力衰竭患者的影响
Br J Clin Pharmacol. 2020 Jul;86(7):1346-1356. doi: 10.1111/bcp.14248. Epub 2020 Mar 10.
7
Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance.抑制钠-葡萄糖共转运蛋白可改善心功能。
Int J Mol Sci. 2019 Jul 4;20(13):3289. doi: 10.3390/ijms20133289.
8
Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.胰岛素抵抗状态下的心肌缺血再灌注损伤:SGLT1 而非 SGLT2 在饮食诱导肥胖中发挥代偿性保护作用。
Cardiovasc Diabetol. 2019 Jul 1;18(1):85. doi: 10.1186/s12933-019-0889-y.
9
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.索格列净:首个双重 SGLT 抑制剂:当前展望与前景。
Cardiovasc Diabetol. 2019 Feb 28;18(1):20. doi: 10.1186/s12933-019-0828-y.
10
Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.SGLT2 抑制剂的直接心血管影响:机制和效应。
Heart Fail Rev. 2018 May;23(3):419-437. doi: 10.1007/s10741-017-9665-9.